Article
Mannan-binding lectin enhances susceptibility to visceral leishmaniasis
Registro en:
SANTOS, I. K. F. M. et. Mannan-Binding Lectin Enhances Susceptibility to Visceral Leishmaniasis. Infection and Immunity, p. 5212–5215, 2001.
0019-9567
10.1128/IAI.69.8.5212-5215.2001
Autor
Santos, Isabel Kinney Ferreira de Miranda
Costa, Carlos Henrique Nery
Krieger, Henrique
Feitosa, Marly Furlan
Zurakowski, David
Fardin, Babak
Gomes, Regis Bernardo Brandim
Weiner, Debra L
Harn, Donald A
Ezekowitz, R Alan B
Epstein, Judith E
Resumen
Gomes, Regis Bernardo Brandim. “Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta à informação no documento”. Conselho Nacional de Desenvolvimento Científico e Tecnológico—CNPq (grant 20.1145/95-2 to
I.K.F.D.M.S.), World Health Organization (grant M8/181/4/C.256 to C.H.N.C.), Pediatric Scientist Development Program (NICHD grant K12-HD00850 to J.E.E.), and the National Institutes of Health. Levels of the serum opsonin mannan-binding lectin (MBL) were directly correlated with the probability of developing visceral leishmaniasis. Monocytes infected with MBL-opsonized Leishmania chagasi promastigotes secreted higher levels of tumor necrosis factor alpha and interleukin-6 than cells infected with nonopsonized parasites. Our findings indicate that MBL can modulate the clinical outcome of infection with L. chagasi and the function of infected macrophages.